Follicular Dendritic Cell Staining Pattern as a Prognostic Marker for the Watch-and-Wait Policy in Patients with Gastrointestinal Follicular Lymphoma
Digestion · 09.09.2026 · 1-1
DOI: 10.1159/dig/acmag016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestion, online erschienen am 09.09.2026. Verfasst von Akira Tari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Chugoku Central Hospital, Fukuyama, Japan, 10206regent@gmail.com. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Introduction
Gastrointestinal follicular lymphoma (GI-FL) patients with low tumor burden are often managed with a “watch-and-wait” (W&W) strategy, but regular endoscopic examinations impose a significant burden. We investigated whether the follicular dendritic cell (FDC) staining pattern of GI-FL lesions could help identify a lower-risk subgroup of patients during W&W follow-up.
Methods
We studied 76 Japanese patients with GI-FL (September 2003–July 2022), classified by CD21 staining into “duodenal pattern” (n = 57) and “nodal pattern” (n = 19) groups. All patients underwent regular clinical, endoscopic, and imaging follow-up. Progression-free survival, time to treatment required, and overall survival (OS) were compared between the two groups.
Results
Patients with a “duodenal pattern” had better outcomes than those with a “nodal pattern.” In the “duodenal pattern” group, 25 of 57 patients (43.9%) progressed, but only 9 (15.8%) required treatment. In the “nodal pattern” group, 14 of 19 patients (73.7%) progressed and all required treatment; 8 (42.1%) developed local compressive symptoms necessitating immediate treatment, versus none in the “duodenal pattern” group. OS was excellent in both groups.
Conclusion
The FDC staining pattern of the tumor is a useful marker for the management of patients with GI-FL. Patients with an FDC “duodenal pattern” have slower disease progression and rarely require treatment. These findings suggest that the “duodenal” FDC pattern may help identify candidates for future prospective studies of individualized or de-escalated surveillance, which could ultimately reduce the physical and financial burden of follow-up while maintaining good outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Chugoku Central Hospital, Fukuyama, Japan, 10206regent@gmail.com.
- Department of Internal Medicine, Takanobashi Central Hospital, Hiroshima, Japan, 10206regent@gmail.com.
- Department of Gastroenterology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan, 10206regent@gmail.com.
- Department of Hematology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan.
- Department of Gastroenterology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.
- Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Zitieren
APA
Tari, A., Asaoku, H., Okatani, T., Boda, K., Okanobu, H., Tanaka, T., Koga, T., & Yoshino, T. (2026). Follicular Dendritic Cell Staining Pattern as a Prognostic Marker for the Watch-and-Wait Policy in Patients with Gastrointestinal Follicular Lymphoma. Digestion, 1-1. https://doi.org/10.1159/dig/acmag016
Vancouver
Tari A, Asaoku H, Okatani T, Boda K, Okanobu H, Tanaka T, et al. Follicular Dendritic Cell Staining Pattern as a Prognostic Marker for the Watch-and-Wait Policy in Patients with Gastrointestinal Follicular Lymphoma. Digestion. 2026:1-1. doi:10.1159/dig/acmag016
BibTeX
@article{Tari2026,
author = {Tari, Akira and Asaoku, Hideki and Okatani, Takeshi and Boda, Kazuki and Okanobu, Hideharu and Tanaka, Takehiro and Koga, Tadashi and Yoshino, Tadashi},
title = {Follicular Dendritic Cell Staining Pattern as a Prognostic Marker for the Watch-and-Wait Policy in Patients with Gastrointestinal Follicular Lymphoma},
journal = {Digestion},
year = {2026},
pages = {1--1},
doi = {10.1159/dig/acmag016}
}
EUVIMED